Stati Uniti - inglese - NLM (National Library of Medicine)

baxter healthcare corporation - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g in 50 ml - cefepime injection is indicated for pneumonia (moderate to severe) caused by streptococcus pneumoniae, including cases associated with concurrent bacteremia, pseudomonas aeruginosa, klebsiella pneumoniae, or enterobacter species. cefepime injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14)]. cefepime injection is indicated for uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by escherichia coli or klebsiella pneumoniae, when the infection is severe, or caused by escherichia coli, klebsiella pneumoniae, or proteus mirabilis, w

Stati Uniti - inglese - NLM (National Library of Medicine)

b. braun medical inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g in 50 ml - cefepime for injection and dextrose injection is indicated for the treatment of pneumonia (moderate to severe) caused by streptococcus pneumoniae (including cases associated with concurrent bacteremia), pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime for injection and dextrose injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)]. cefepime for injection and dextrose injection is indicated for uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by escherichia coli or klebsiella pneumoniae when the

Stati Uniti - inglese - NLM (National Library of Medicine)

sandoz inc - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - cefepime for injection, usp is indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms (see also precautions: pediatric use and dosage and administration ): pneumonia (moderate to severe) caused by streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. empiric therapy for febrile neutropenic patients. cefepime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients. (see clinical studies .) uncomplicated and complicated urinary tract infection

Canada - inglese - Health Canada

apotex inc - cefepime (cefepime hydrochloride) - powder for solution - 1g - cefepime (cefepime hydrochloride) 1g - fourth generation cephalosporins

Canada - inglese - Health Canada

apotex inc - cefepime (cefepime hydrochloride) - powder for solution - 2g - cefepime (cefepime hydrochloride) 2g - fourth generation cephalosporins

Canada - inglese - Health Canada

qilu pharmaceutical co., ltd. - cefepime (cefepime hydrochloride) - powder for solution - 1g - cefepime (cefepime hydrochloride) 1g - fourth generation cephalosporins

Canada - inglese - Health Canada

qilu pharmaceutical co., ltd. - cefepime (cefepime hydrochloride) - powder for solution - 2g - cefepime (cefepime hydrochloride) 2g - fourth generation cephalosporins

Canada - inglese - Health Canada

hikma canada limited - cefepime (cefepime hydrochloride) - powder for solution - 1g - cefepime (cefepime hydrochloride) 1g - fourth generation cephalosporins

Canada - inglese - Health Canada

hikma canada limited - cefepime (cefepime hydrochloride) - powder for solution - 2g - cefepime (cefepime hydrochloride) 2g - fourth generation cephalosporins

Stati Uniti - inglese - NLM (National Library of Medicine)

apotex corporation - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)]. cefepime is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infection is severe, or caused by